**Core Concept**
GnRH agonists are synthetic analogs of **Gonadotropin-Releasing Hormone (GnRH)** that initially stimulate, then downregulate **GnRH receptors**, leading to decreased secretion of **Luteinizing Hormone (LH)** and **Follicle-Stimulating Hormone (FSH)**. This mechanism is utilized in various clinical conditions.

**Why the Correct Answer is Right**
The correct answer is not provided, however, GnRH agonists are used in conditions like **endometriosis**, **uterine fibroids**, and **prostate cancer**. They work by initially stimulating, then downregulating GnRH receptors, leading to a decrease in LH and FSH secretion, which in turn reduces **estrogen** and **testosterone** production.

**Why Each Wrong Option is Incorrect**
**Option A:** Incorrect because GnRH agonists are indeed used in certain conditions, but without the specific options, we cannot determine which one is correct.
**Option B:** Similarly, without the specific options, we cannot assess the correctness of this choice.
**Option C:** This option would be incorrect if it pertained to a common use of GnRH agonists.
**Option D:** This would be incorrect if it also described a typical application of GnRH agonists.

**Clinical Pearl / High-Yield Fact**
A key point to remember is that GnRH agonists are used to treat conditions that are hormone-sensitive, such as **prostate cancer** and **endometriosis**, by reducing hormone production.

**Correct Answer:**